Catalyst Wire Dossier Catalyst Wire Dossier

AFP-C332T

· Adaptimmune Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AFP-C332T, covering 2025-08-15 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: AFPᶜ³³²T in Advanced HCC [Phase 1]

See pricing